| Initial public offer of up to [*] equity shares of face value of Re. 1 each (equity shares) of Dr. Agarwal's Health Care Limited (company) for cash at a price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share) (offer price) aggregating up to Rs. [*] crores comprising a fresh issue of up to [*] equity shares of face value of Re. 1 aggregating up to Rs. 300.00 crores by the company (fresh issue) and an offer for sale of up to 69,568,204 equity shares of face value of Re. 1 aggregating up to
Re. [*] crores (offered shares) by the selling shareholders, consisting of up to 2,253,913 equity shares of face value of Re. 1 aggregating up to
Rs. [*] crores by Amar Agarwal, up to 2,704,696 equity shares of face value of Re. 1 aggregating up to Rs. [*] crores by Athiya Agarwal, up to 2,961,614 equity shares of face value of Re. 1 aggregating up to Rs. [*] crores by
Adil Agarwal, up to 5,242,630 equity shares of face value of Re. 1 aggregating up to Rs. [*] crores by Anosh Agarwal, up to 230,035 equity shares of face value of Re. 1 aggregating up to Rs. [*] crores by Ashvin Agarwal, up to 1,963,172 equity shares of face value of Re. 1 aggregating up to Rs. [*] crores by Agarwal's Eye Institute (collectively the promoter selling shareholders), up to 7,083,010 equity shares of face value of Re. 1 aggregating up to Rs. [*] crores by Arvon Investments Pte. Ltd., up to 16,148,150 equity shares of face value of Re. 1 aggregating up to Rs. [*] crores by Claymore Investments (Mauritius) Pte. Ltd., and up to 30,755,592 equity shares of face value of Re. 1 aggregating up to Rs. [*] crores by Hyperion Investments Pte. Ltd. (collectively the investor selling shareholders), up to 112,696 equity shares of face value of Re. 1 aggregating up to Rs. [*] crores by Farah Agarwal, up to 112,696 equity shares of face value of Rs. 1 aggregating up to Rs. [*] crores by Urmila Agarwal (collectively the other selling shareholders) (the promoter selling shareholders, the other selling shareholders and the investor selling sharehodlers, collectively referred to as the selling shareholders) and such equity shares offered by the selling shareholders (offer for sale, and together with the fresh issue, the offer).
The company, in consultation with the brlms, may consider an issue of specified securities, as may be permitted under applicable law, with the roc (pre-ipo placement). The pre-ipo placement, if undertaken, will be at a price to be decided by the company, in consultation with the brlms. If the pre-ipo placement is completed, the amount raised pursuant to the pre-ipo placement will be reduced from the fresh issue, subject to compliance with rule 19(2)(b) of the securities contracts (regulation) rules, 1957, as amended. The pre-ipo placement, if undertaken, shall not exceed 20% of the size of the fresh issue. prior to the completion of the offer, the company shall appropriately intimate the subscribers to the pre-ipo placement, prior to allotment pursuant to the pre-ipo placement, that there is no guarantee that the company may proceed with the offer or the offer may be successful and will result into listing of the equity shares on the stock exchanges. Further, relevant disclosures in relation to such intimation to the subscribers to the pre-ipo placement (if undertaken) shall be appropriately made in the relevant sections of the red herring prospectus and the prospectus.
The offer includes a reservation of up to [*] equity shares of face value of Re. 1, aggregating up to Rs. [*] crores (constituting up to [*]% of the post-offer paid-up equity share capital), for subscription by eligible employees (employee reservation portion) and a reservation of up to [*] equity shares aggregating up to Rs. [*] crores (constituting up to [*]% of the postissue paid-up equity share capital) for subscription by eligible aehl shareholders (shareholder reservation portion). The offer less the employee reservation portion and the shareholder reservation is hereinafter referred to as the net offer. The offer and the net offer shall constitute [*] % and [*] % of the post-offer paid-up equity share capital of the company, respectively.
The face value of equity shares is Re. 1 each. The offer price is [*] times the face value of the equity shares. The price band and the minimum bid lot will be decided by the company.
|
